secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tenaya Therapeutics, Inc. (TNYA)
CIK:        0001858848
Form:       8-K
Filed at:   2026-01-30T23:59:59+00:00
Accession:  0001193125-26-032017
Event type: regulatory
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01, 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Tenaya receives Nasdaq bid price deficiency notice; 180-day cure period to July 27, 2026
--------------------------------------------------------------------------------

- Nasdaq notified Tenaya on Jan 28, 2026 that stock failed to meet $1.00 minimum bid price for 30 consecutive business days through Jan 27, 2026.
- Company has 180 days, until July 27, 2026, to regain compliance by maintaining $1.00 closing bid for 10 consecutive business days.
- If not cured, Tenaya may transfer to Nasdaq Capital Market for second 180-day compliance period, subject to eligibility and application.
- Board approved increase in Inducement Plan shares by 2,161,000 to a total of 3,361,000 shares for new-hire equity grants.
- Inducement Plan amendment effective Jan 26, 2026; awards limited to new employees as material inducement under Nasdaq rules.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1858848/000119312526032017/0001193125-26-032017-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1858848/000119312526032017/tnya-20260126.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-032017

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer